Jul 18, 2021
FRIDAY, July 16, 2021 (HealthDay News) Pfizer Inc. has agreed to pay $345 million in a proposed settlement to resolve lawsuits over steep EpiPen price increases.
In 2016, a number of class-action lawsuits were filed against Pfizer and its subsidiaries Meridian Medical Technologies Inc. and King Pharmaceuticals, alleging they engaged in anticompetitive conduct related to EpiPen, the
Associated Press reported.
Court documents filed Thursday in federal court in Kansas City, Kansas, show that Pfizer and its two subsidiaries asked the court to give preliminary approval to the settlement, according to Kansas City’s NPR station KCUR-FM, the
AP reported. In an email to KCUR-FM, a Pfizer spokesperson denied any wrongdoing by the company and said the settlement was sought to avoid “the distraction of continued litigation and focus on breakthroughs that change patients’ lives.”
Today
Mostly cloudy skies early then heavy thunderstorms developing this afternoon. Storms may contain strong gusty winds. High around 80F. Winds WSW at 5 to 10 mph. Chance of rain 90%..
Tonight
Mostly cloudy with scattered thunderstorms mainly during the evening. Storms may contain strong gusty winds. Low 64F. Winds light and variable. Chance of rain 60%. Updated: July 17, 2021 @ 10:17 am
Stocks close lower, EpiPen price hike settlement agreement
NEW YORK (AP) Stocks closed lower on Wall Street today, pulling major indexes a bit further below the record highs they marked at the start of the week. Investors continue to focus on where the economy is headed as the pandemic wanes, and also on the latest company earnings reports. The S&P index fell 0.3%. Technology and communications stocks were the biggest weights on the market. Banks, which have been reporting mostly solid financial results, also fell as bond yields headed lower. Jobless claims fell to another pandemic low.
KANSAS CITY, Kansas (AP) Pfizer Inc. and two of its subsidiaries have agreed to pay $345 million under a proposed settlement to resolve litigation over EpiPen price hikes. Pfizer and its subsidiaries Meridian Medical Technologies Inc. and King Pharmaceuticals, asked a federal court to grant preliminary approval to the settlement today. Numerous class action lawsuits were filed alleging the comp
Pfizer Agrees to Pay $345 Million Under Proposed Settlement Over EpiPen Price Hikes
By the Associated Press.
Pfizer Inc. and two of its subsidiaries have agreed to pay $345 million under a proposed settlement to resolve litigation over EpiPen price hikes.
The New York-based Pfizer and its subsidiaries–Maryland-based Meridian Medical Technologies Inc. and Tennessee-based King Pharmaceuticals–asked a federal court in Kansas City, Kansas, on Thursday to grant preliminary approval to the settlement.
Numerous class action lawsuits were filed alleging the companies engaged in anticompetitive conduct. EpiPens are auto-injectable devices that deliver the drug epinephrine and are used to treat life-threatening allergic reactions.
Pfizer and two of its subsidiaries agree to pay $345 million settlement over EpiPen price hikes Updated: 5:20 PM EDT Jul 15, 2021 Associated Press Share Updated: 5:20 PM EDT Jul 15, 2021
Hide Transcript
Show Transcript REPORTER: SEVEN-YEAR-OLD AIDEN SEGOOL LOOKS JUST LIKE ANY OTHER KID ABOUT TO START SCHOOL. BUT WHAT YOU CAN’T SEE IS THAT AIDEN HAS A LIFE-THREATENING ALLERGY TO DAIRY AND EGGS. EVERYONE GETS TO EAT AROUND ME, BUT I CAN’T. REPORTER: IT IS SOMETHING HIS PARENTS DISCOVERED THE FIRST TIME HE TRIED YOGURT AS A BABY. ALL OF A SUDDEN, SOMETHING DIDN’T SEEM RIGHT. I GOT NERVOUS, I TOOK HIS SHIRT OFF AND HE WAS COVERED IN HIVES. REPORTER: MOM ALYSON WAS PRESCRIBED AN EPINEPHRINE AUTO-INJECTOR, THEN TRAINED HOW TO USE IT. AND SHE LEARNED TO ASK THE PHARMACY ABOUT ITS EXPIRATION DATE. THEY’RE GRABBING ONE OFF THE SHELF THAT’S EXPIRING IN 4 MONTHS. NOT ONLY DO YOU HAVE TO GO BACK IN 4 MONTHS BUT YOU’VE SPENT THE MONEY